a Lifestyle Intervention Programme Using Mobile Application vs Booklet for Adults With Metabolic Syndrome
perjantai 1. huhtikuuta 2022 päivittänyt: Dr Eliza Wong, The Hong Kong Polytechnic University
A Multicentre Randomized Controlled Trial of the Effectiveness of a Lifestyle Intervention Programme Using Mobile Application vs Booklet for Adults With Metabolic Syndrome
The study aims to compare the effect of a lifestyle intervention programme (LIP) using mobile application (MetS app) vs using booklet for MetS adults living in the community.
Tutkimuksen yleiskatsaus
Tila
Valmis
Ehdot
Interventio / Hoito
Yksityiskohtainen kuvaus
The study aims to compare the effect of a lifestyle intervention programme (LIP) using mobile application (MetS app) vs using booklet for MetS adults living in the community.
Methods A multi-site randomized controlled trial (RCT) with three arms, namely, MetS app group (Group A), booklet group (Group B), and control group (group C). Three hundred and sixty subjects will be recruited from six community centers and randomized into either one arm. Inclusion criteria are those MetS adult, able to use a smart phone. Group a participants will receive a 30-minute educational session and a MetS app while Group B will receive same educational session and a MetS booklet and the control group receive a placebo booklet only. The MetS app or booklet, has been well developed by the team with the support of internal grant, aims to support MetS individual's self- monitoring and record of health measures (body weight, blood pressure, waist circumference) and exercise. The primary outcomes of this study include the body weight and total physical exercise (GSLTPAQ). The secondary outcomes include cardiometabolic risk factors, cardiovascular endurance, self-efficacy for exercise (SEE) and stress level (PSS-10). Data will be collected at baseline (T1), 4 week (T2) and week 12 (T3) and week 24 (T4). SPSS and Generalized Estimating equations (GEE) model will be employed for data analysis.
Significance This study will provide empirical evidence and inform about the effective way to enhance patient's self-management of MetS, exercise sustainability that will be beneficial to clients' health.
Opintotyyppi
Interventio
Ilmoittautuminen (Todellinen)
264
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.
Opiskelupaikat
-
-
-
Hong Kong, Hong Kong, 00
- Wan chai Methodist Centre for the Seniors
-
-
Osallistumiskriteerit
Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.
Kelpoisuusvaatimukset
Opintokelpoiset iät
18 vuotta - 99 vuotta (Aikuinen, Vanhempi Aikuinen)
Hyväksyy terveitä vapaaehtoisia
Ei
Sukupuolet, jotka voivat opiskella
Kaikki
Kuvaus
Inclusion Criteria:
- Ethnic Chinese client who has a smart phone.
- Adult age 18 or over
MetS Clients with central obesity (male >90 cm , female > 80cm ) plus two items of the followings :
- Raised triglycerides ≥ 150 mg/dL (1.7 mmol/L) or specific treatment for this lipid abnormality
- Reduced HDL cholesterol < 40 mg/dL (1.03 mmol/L) in males < 50 mg/dL (1.29 mmol/L) in females or treatment for this lipid abnormality
- Raised blood pressure systolic BP ≥ 130 or diastolic BP ≥ 85 mm Hg or treatment of previously diagnosed hypertension (HT)
- Raised fasting plasma glucose (FPG) ≥ 100 mg/dL (5.6 mmol/L), or previously diagnosed type 2 diabetes (DM) -
Exclusion Criteria:
- Clients with physical, mental, visual, or cognitive impairments with regular medical follow-ups and treatment, and those who have musculoskeletal disorders or other disabling diseases that may limit the practice of walking exercise will be excluded. Client receiving prescription of medication for weight reduction will be excluded as well.
Opintosuunnitelma
Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Tukevaa hoitoa
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Kolminkertaistaa
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Active Comparator: App group
Participants will receive the MetS mobile application (MetS app) instalment and briefing by a research assistant (RA2) after the educational talk.
They will be able view the booklet content in their own smart phone.
In addition, a membership area provides individual support of self- health monitoring, goal setting for their exercise plan and exercise record.
|
Intervention group the participants will receive a Lifestyle Intervention Program (LIP) with the support of MetS mobile application (MetS app).
The MetS app support include app installment and briefing by a research assistant after the educational talk.
The participants can view the similar knowledge content related to metabolic syndrome in their own smart phone.
In addition, a membership area provides individual support of self- health monitoring, goal setting of exercise plan and exercise record.
A user guide of the MetS app will be provided to the participants to take home after the briefing.
|
|
Active Comparator: Booklet group
The participants will additionally receive a Hong Kong version Lifestyle Intervention Programme (LIP) booklet to take home and use for 20 weeks.
The major component of the LIP booklet consists of fact of metabolic syndrome, advise of diet, exercise, medication, life style and stress management.
|
The participants will additionally receive a Hong Kong version LIP booklet to take home and use for 24 weeks.
The major component of the LIP booklet consists of fact of metabolic syndrome, advise of diet, exercise, medication, life style and stress management.
|
|
Active Comparator: control group
Participants will be advised to maintain their usual activities.
They will additionally receive a placebo health leaflet.
The health leaflets are produced by Department of Health and commonly distributed to the general public.
For the ethical reason, those control group participants are freely to receive the LIP booklet after completion of the study at 20 weeks.
|
The participants will additionally receive a Hong Kong version LIP booklet to take home and use for 24 weeks.
The major component of the LIP booklet consists of fact of metabolic syndrome, advise of diet, exercise, medication, life style and stress management.
Participants will be advised to maintain their usual activities.
They will additionally receive a placebo health leaflet.
The health leaflets are produced by Department of Health and commonly distributed to the general public.
For the ethical reason, those control group participants are freely to receive the LIP booklet after completion of the study at 24 weeks.
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Body weight
Aikaikkuna: 24 weeks
|
change in body weight will be measured at the same scale in the follow up centre
|
24 weeks
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Total physical exercise
Aikaikkuna: 24 weeks
|
Total physical exercise will be quantified with a modified version of the GSLTPAQ [31-32].
The patients will be instructed to indicate the amount of exercises undertaken and rank the exercises in the order of difficulty (strenuous, moderate, or mild).
The total score will be calculated.
This measure has been widely used in empirical studies and shown to exhibit good Psychometric properties [31-32]
|
24 weeks
|
|
Chinese version of Self-Efficacy for Exercise (SEE-C)
Aikaikkuna: 24 weeks
|
The SEE-C consists of nine items, and responses are made on a 0-10 scale.
The sum of the responses to all nine items yields the final composite score ranging from 0-90.
The C-SE has been proved to be reliable with good psychometric properties of Cronbach's alpha coefficient 0.75 for Taiwan Chinese older adults [33-34].
|
24 weeks
|
|
Cardiovascular endurance test.
Aikaikkuna: 24 weeks
|
it is a three -minute step test to test the cardiovascular functional endurance after exercise across the age span and gender.
A participant step on and off of a 12 inch high bench / or stair for 3 minutes.
Then pulse will be taken afterward while the participant remain standing.
Compare the heart rate with the table according to the age and gender to determine the fitness in a range of 7 score from excellent, good, above average, average, below average, poor and very poor .
Validity of this test has been established in previous studies.
[35] .
|
24 weeks
|
|
Perceived stress scale (PSS-10)
Aikaikkuna: 24 weeks
|
Ten self-report items measure the degree to which situations in one's life are appraised as stressful and the current levels of experienced stress in the last month.
Summative scores range from 0 to 40, with a higher score indicating higher stress level.
These scores have been used as outcome measures of experienced levels of stress.
The psychometric properties of the Chinese version of PSS-10 were satisfactory with Cronbach's alphas >0.75 in a local study for Chinese cardiac patients.
[36]
|
24 weeks
|
|
hospitalization
Aikaikkuna: 24 weeks
|
hospitalization frequency will be asked
|
24 weeks
|
|
app usage
Aikaikkuna: 24 weeks
|
MetS app usage (frequency per week) will be collected by RA by retrieving the data from the app server for the intervention group monthly.
|
24 weeks
|
|
booklet usage
Aikaikkuna: 24 weeks
|
Booklet usage (frequency per week) will be collected for the control group at baseline, week 4,12 and 24
|
24 weeks
|
|
Waist circumference (cm)
Aikaikkuna: 24 weeks
|
The Waist circumference is measured by a trained RA with a tape (cm) at the midpoint between the top of the iliac crest and the lower margin of the last rib in the standing position at the end of several consecutive natural breaths
|
24 weeks
|
|
blood pressure
Aikaikkuna: 24 weeks
|
Systolic and diastolic blood pressure (mmHg) is measured by a trained RA using same equipment.
Data will be collected by RA
|
24 weeks
|
|
Lipid level
Aikaikkuna: 24 weeks
|
A drop of blood sample will be taken by using a finger stick to measure LDL cholesterol (mmol/L), and HDL cholesterol (mmol/L), and triglycerides (mmol/L).
The data can be analysed immediately by using auto-analyser and the participants are asked to have 8 hours fasting.
Data will be collected by RA
|
24 weeks
|
|
Fasting blood glucose
Aikaikkuna: 24 weeks
|
Fasting blood glucose level (mmol/L) : the participants are asked to have 8 hours fasting before blood taken.
A drop of blood will be collected by finger stick by RA using same glucometer to measure the fasting blood glucose level
|
24 weeks
|
Yhteistyökumppanit ja tutkijat
Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.
Sponsori
Tutkijat
- Päätutkija: Eliza ML Wong, HKPolyu
Opintojen ennätyspäivät
Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan julkisella verkkosivustolla.
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Torstai 1. elokuuta 2019
Ensisijainen valmistuminen (Todellinen)
Keskiviikko 1. joulukuuta 2021
Opintojen valmistuminen (Todellinen)
Sunnuntai 2. tammikuuta 2022
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Tiistai 11. joulukuuta 2018
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Lauantai 15. joulukuuta 2018
Ensimmäinen Lähetetty (Todellinen)
Keskiviikko 19. joulukuuta 2018
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Maanantai 4. huhtikuuta 2022
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Perjantai 1. huhtikuuta 2022
Viimeksi vahvistettu
Perjantai 1. huhtikuuta 2022
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- HSEARS20181211005
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
EI
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Ei
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Ei
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .